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Supplementary information appendix 
 
Supplementary Materials and Methods  
Plasmid construction 
To make plasmids pPKB1 and pPKB2, the AUP1 reading frame full length and an 
alternative insert lacking 34 amino acids from the N-terminal of the reading frame, 
respectively, were amplified using a PCR reaction. The primers P1 (5'-
ATACTAACTAGTTACAACATGCGGCTGGGGAATCT ATG-3' ) and P2 (5'-
ATACTAATCGATTTAGTTTAATTTTGTTTCGTTAGATTG-3) contain ClaI and SpeI linkers (SI 
appendix table III). The PCR product was digested then with ClaI and SpeI and ligated into a 
ClaI and SpeI digested pCU416.  To construct plasmid PKB32, the Mdh1-GFP open reading 
frame (ORF) was amplified by HAY840 yeast genomic DNA using a PCR reaction and 
oligonucleotides primers P7 Forward: 5'-ATACTAACTAGTTACAACA 
TGTTGTCAAGAGTAGCTAAAC-3' and P8 Reverse: 5'-ATACTAATCGATGACCTCATACTATACCTG-3' 
containing ClaI and SpeI restriction sites (SI appendix table IV). The PCR product was digested 
with ClaI-SpeI and ligated into a ClaI and SpeI digested pCU416, generating a fusion protein 
under the control of the CUP1 promoter. Plasmid PKB65 was generated by cloning the Mdh1-
GFP reading frame, together with 800 bases of 5’ and 500 bases of 3’ sequences was amplified 
using a PCR and primers P5 Forward: 5'-ATACTAGGATCCC AAAAGATCGACGCAATG-3' and P6 
Reverse: 5'-ATACTAGAGCTCGACCTCATACTATACCTG-3' (table 4) containing BamHI and SacI 
linkers. The PCR product was digested with BamHI-SacI and ligated into a BamHI-SacI 
digested pRS415. All the plasmids were verified by sequencing (Hylabs, Rehovot). 
 
Site directed mutagenesis 
 Site directed mutagenesis protocol was carried out according to the Stratagene 
QuikChange system. Pfu DNA Polymerase (Fermentas) was used with a thermocycling 
protocol followed by removal of the parental strands with DpnI digestion. Thermocycling 
conditions were as follows: Initial denaturation at 95oC for 2 min, then (steps 2-4), 30 sec at 95 
oC, 60 sec at 55 oC, and 12 min at 68 oC. Steps 2-4 repeated for 18 cycles. PCR products were 
treated with DpnI (fermentas) for 1 hr at 37 oC, and precipitated using with 70% ethanol. DNA 
pellets were then dried and resuspended with 20 µl TE buffer pH 8. All mutagenesis products 
were transformed into E. coli DH5a, and mutations were verified by sequencing. The 
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oligonucleotide primers used to create site-directed MDH1-GFP variants and combined 
variants are listed in SI appendix Table III. 
 
 
Culture conditions 
Yeast were grown in synthetic dextrose medium (0.67% yeast nitrogen base w/o amino 
acids (Difco), 2% glucose, auxotrophic requirements and vitamins as required) or in SL 
medium (0.67% yeast nitrogen base w/o amino acids (Difco), 2% lactate pH 6, 0.1% glucose, 
auxotrophic requirements and vitamins as required). All culture growth and manipulation were 
at 26 0C. Yeast transformation was according to Gietz and Woods (1). 
For nitrogen starvation experiments, cells were grown to mid-log phase (OD600 of 0.4-
0.6) in synthetic dextrose medium (SD), washed with distilled water, and resuspended in 
nitrogen starvation medium (0.17 YNB-N (Difco), 2% glucose) for the times indicated in 
individual experiments. Overexpression studies with CUP1 promoter-based vectors were 
carried out by supplementing the medium with 5 µM CuSO4, for both control (empty vector) 
and overexpressing cells.  
 
Calculation of statistical significance of differences in % free GFP signals from 
immunoblots 
Data (% free GFP) were log-transformed before analysis in order to stabilize variances. 
A repeated measures ANOVA was performed to compare mutants and proteins simultaneously. 
Thereafter, mutants were compared for each protein and proteins were compared for each 
mutant by the Tukey HSD test (p<0.05). ANOVA analysis was carried out using JMP 12 
software.  
 
Generation of selectivity profile comparisons and heat maps 
 To compare between different genotypes, % free GFP values which were recorded 
from immunoblots of Mdh1-GFP, Aco1-GFP, Aco2-GFP, Qcr2-GFP and Idp1-GFP were 
normalized, such that each value of % free GFP was divided by the average value of all % free 
GFP measured for the same protein over all genotypes. This centered the data distribution such 
that all proteins contributed equally to the correlation calculation. Normalized data points of 3 
biological replicates were averaged. We then calculated a Pearson correlation value (r 
(correlation coefficient) and p – values (significance of correlation) between all phenotype 
pairs (vector of normalized averaged % free GFP per protein) using the rcorr function in R 
(Hmisc package). A heat map was generated using the heatmap.2 function in R (gplots 
package). The heat map cells contains the r correlation measured and colored from negative 
correlation in red to positive correlation in yellow. The dendogram was generated by 
calculating the Euclidean distance measure between correlation vectors of each genotype using 
the complete linkage method. 
 
Cell fractionation. Cells (20 OD600 units) were collected by centrifugation at 3,500 
xg, 5 min, 4oC. The cells were spheroplasted in medium containing 1 M sorbitol and 0.6 mg/ml 
zymolyase (0.67 % yeast nitrogen base, 2 % glucose, auxotrophic requirements and vitamins 
as required, 1 M sorbitol, 40 mM HEPES pH 7, 0.6 mg/ml zymolase) for 30 min at 37oC. 
Spheroplasts were collected by centrifugation at 200xg g for 5 min. The spheroplasts were 
resuspended on ice in lysis buffer (0.2 M sorbitol, 50 mM potassium acetate, 2 mM EDTA, 40 
mM HEPES pH 7, plus protease inhibitors), transferred to a pre-cooled dounce homogenizer 
and dounced 15 times with a tight fitting pestle. The lysate was then transferred to eppendorf 
tubes and centrifuged at 300 xg, 4oC, 5 min.  1 ml of cleared supernatant was saved as total 
extract fraction (T). The rest was transferred to clean eppendorf tubes and centrifuged at 
13.000x g, 10 min, 4oC. 1 ml of the supernatant was labeled as S13 (cytosolic proteins). The 
pellet was labeled as P13. The S13 and total extract fractions (1 ml each) were precipitated 
with 10% cold TCA by adding 500 μl of 30% TCA, while the P13 fraction was first 
resuspended in 1 ml lysis buffer and then precipitated with 10 % TCA.  For immunoblot 
analysis, 0.5 OD600 equivalents were loaded per lane on SDS-PAGE gels.  
 
Preparation of whole-cell extracts for western blot analysis. Cells (10 OD600 units) 
were treated with 10% cold trichloroacetic acid (TCA) and washed three times with cold 
acetone. The dry cell pellet was then resuspended in 100 μl cracking buffer (50 mM Tris pH 
6.8, 6 M urea, 1 mM EDTA, 1% SDS) and vortexed in Tomy MT-360 microtube mixer at 
maximum speed, with an equal volume of acid-washed glass beads (425-600 µm diameter), 
for a total of 30 min. Lysates were clarified by centrifugation at 17,000 xg for 5 min and total 
protein was quantified in the supernatant using the BCA protein assay (Thermo Scientific, 
Rockford, IL). SDS loading buffer (final concentrations of 100 mM Tris pH 6.8, 20% 
glycerol, 2% SDS, 500 mM b-mercaptoethanol) was added to the lysate and the samples 
were warmed to 60 oC for 5 min prior to loading on gels. ImageJ software was used for band 
quantification. 
 
Immunoblotting. SDS-10% polyacrylamide gels were transferred to nitrocellulose 
membrane by using either a wet or semidry blotting transfer system. Membranes were blocked 
for 1 h with TPBS (137 mM NaCl, 2.7 mM KCL, 10 mM Na2HPO4, 1.8 mM KH2PO4, 1 % 
Tween and 5 % milk powder (BD Difco Skim Milk), followed by incubation with anti-GFP 
rabbit (1:5000) for 1.5 h, then washed 4x 2 min with TPBS, incubated for 1.5 h with HRP 
conjugated secondary antibody (1:10000). The membranes were then washed 4x with TPBS, 
incubated with SuperSignal Chemiluminescence substrate (Thermo Scientific), and exposed to 
a Molecular Imager ChemiDocTM XRS imaging system.  
 
 
 
Supplementary figure legends 
 
 
Supplementary Figure 1. All the mitochondrial reporters used in this study generate free 
GFP in an Atg32- dependent fashion. Cells expressing Qcr2-GFP, Idp1-GFP, Aco1-GFP 
and Aco2-GFP were grown, collected and analyzed as described in the legend to Figure 1B. 
 
Supplementary Figure 2. A sample blot comparing free GFP release from Aco1-GFP in 
WT (HAY75), aup1D (HAY809), ptc5D (PKY37),  pkp1D (PKY61), pkp2D (PKY70) and 
pkp1D pkp2D (PKY629) cells. Experimental details are as described in the legend to Figure 
1.  
 
Supplementary Figure 3. A sample blot comparing free GFP release from Aco2-GFP in 
WT, aup1D, ptc5D, pkp1D, pkp2D, and pkp1D pkp2D cells. Experimental details are as 
described in the legend to Figure1. 
 
Supplementary Figure 4. A sample blot comparing free GFP release from Qcr2-GFP in 
WT, aup1D, ptc5D, pkp1D, pkp2D, and pkp1D pkp2D cells. Experimental details are as 
described in the legend to Figure 1. 
 
Supplementary Figure 5. A sample blot comparing free GFP release from Idp1-GFP in 
WT, aup1D, ptc5D, pkp1D, pkp2D, and pkp1D pkp2D cells. Experimental details are as 
described in the legend to Figure 1. 
 
Supplementary Figure 6. A sample blot comparing free GFP release from Mdh1-GFP in 
WT, aup1D, ptc5D, pkp1D, pkp2D, and pkp1D pkp2D cells. Experimental details are as 
described in the legend to Figure 1. 
 
Supplementary Figure 7. A sample blot comparing free GFP release from mtDHFR-GFP 
in WT, aup1D, ptc5D, pkp1D, pkp2D, and pkp1D pkp2D cells. Experimental details are as 
described in the legend to Figure1. 
 
 
Supplementary Figure 8. The general differential centrifugation fractionation properties 
of the T199A mutant in Mdh1-GFP are identical to those of the wild-type. Cells 
expressing WT Mdh1-GFP (PKY366) and the T199A (PKY368) variant were grown, lysed 
and fractionated into total lysate, 13,000 xg pellet and 13,000 xg supernatant as described in 
“Materials and Methods”. GAPDH was used as a cytosolic marker.  
 
Supplementary Figure 9. Free GFP release patterns from different Mdh1-GFP variants 
expressed in WT yeast cells. Cells (PKY365) were treated and sampled as described in the 
legends to Figures 4C and 4D. 
 
Supplementary Figure 10. Expression of Mdh1T199A-GFP does not affect mitophagy of 
Qcr2-RFP. Cells (PKY535) co-expressing Qcr2-RFP and Mdh1-GFP, Mdh1T199A-GFP or 
Mdh1T59A were treated and sampled as described in the legends to Figures 7A and 7B. (A) 
Samples were immunoblotted and probed with anti-GFP antibodies. (B) The same samples 
were probed with anti-RFP antibodies. WT cells not expressing RFP were also tested in the 
a-RFP blot as a specificity control. (C) Quantification and reproducibility of normalized data 
from 4 independent biological repetitions. Mdh1-GFP data were normalized to WT Mdh1-
GFP and Qcr2-RFP data were normalized to the Qcr2-RFP data of samples from cells 
expressing WT Mdh1-GFP.  
 
Supplementary Figure 11. Alanine point mutants do not affect Mdh1 function and 
cellular physiology. Cells (mdh1D, strain PKY365) harboring empty vector or plasmids 
encoding MDH1 and the various MDH1 point mutants were sown at OD 0.08 on synthetic 
lactate medium, and optical density at 600 nm was recorded over 72 hours.  
 
Supplementary Figure 12. Comparison of endogenous expression levels versus CUP1 
promoter-driven overexpression for Idp1-GFP and Mdh1-GFP. Cells expressing 
endogenous Idp1-GFP and Mdh1-GFP (PKY15 and PKY17 (WT) ; PKY186 and 133 
(aup1D) ) were grown in complete minimal medium and 30 µg  protein samples were 
analyzed by immunoblotting. Cells overexpressing Mdh1-GFP and Idp1-GFP under the 
CUP1 promoter  from plasmids (PKY67 and  PKY 302 (WT); PKY146 and PKY303 
(aup1D))  were grown on minimal medium lacking uracil and supplemented with 5 µM 
CuSO4. 30 µg protein samples were analyzed by immunoblotting with anti-GFP antibody.  
 
Supplementary Figure 13. Survival curve in synthetic lactate medium for pkp1D pkp2D 
(PKY672) cells compared with WT (PKY17) cells. Cells were seeded in fresh medium at 
an OD600 of  0.08 and viability was assayed by sampling the cells daily and plating them onto 
SD complete medium. Viable colonies were counted and normalized to day 1. Data shown is 
an average of three independent biological repetitions; bars denote standard error.  
 
Supplementary Figure 14. Segregation of Mdh1-RFP from Qcr2-GFP in WT (PKY1025) 
and aup1D  (PKY1054) cells. Cells co-expressing integrated Mdh1-RFP and Qcr2-GFP were 
imaged on days 1 and 2 of the incubation (to avoid interference from vacuolar signal, top 
panels) and the overlap between the red and green channels was quantified as described in 
‘Materials and Methods’. Graph (bottom) shows quantification of the overlap between the 
two channels using the JACoP script in ImageJ (bars denote SE, N=3 biological repeats). 
Scale bar =1 µm. 
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Supplementary Table I. Statistical significance of the data from Figure 1G. 
Pairwise comparisons of % free GFP values (between different genotypes over 
the same protein, and between different proteins over the same genotype) were 
analyzed using the Tukey HSD test. In each row, means without a common 
lowercase letter differ significantly over proteins. In each column, means without 
a common uppercase letter differ significantly over mutants. Values not 
connected by a common letter are significantly different (Tukey HSD, p<0.05).  
 
 
 
 
 Aco2-GFP Qcr2-GFP Aco1-GFP Mdh1-GFP Idp1-GFP 
WT ABa52.53  ABc2.13  ABb21.33  Ab14.33  Ab12.66  
aup1D Ba34.50  ABb 2.50 Dab5.66  Bb2.00  BCb1.33  
ptc5D ABa40.06  Ac4.30  Aa33.00  Ab13.33  Ab14.00  
pkp1D ABa44.80  cdBA1.72  BCb14.33  Bd0.33  Bc3.00  
pkp2D Aa59.13  ABc1.79  CDb10.00  Bd0.00  Cd0.33  
pkp1D pkp2D Cb0.33  Bb0.00  BCa11.33  Bb0.33  Cb0.33  
Supplementary Table II. Yeast Strains used in this study 
 
 
Strain Genotype Reference/source 
Saccharomyces cerevisiae strains 
HAY75 
Wild type, 
progeny of 
SEY 6211 and 
SEY6210 
MATα leu2-3,112 ura3-52 his3-Δ200 
trp1-Δ901 lys2-801 suc2-Δ9 
(Abeliovich et al. Mol. Biol. 
Cell, 2003) 
HAY809 HAY75, aup1D::HIS5 S.p. (Tal et al., JBC, 2007) 
HAY1239 HAY75, atg32D::G418R (Abeliovich et al., Nat Commun,  
2013) 
TVY1 HAY75, pep4D::LEU2 (Gerhardt et al., J. Biol. Chem, 
1998) 
PKY9 HAY75, ACO2-GFP::G418 R This study 
PKY11 HAY75, ACO1-GFP::G418 R This study 
PKY15 HAY75, IDP1-GFP::G418 R This study 
PKY16 HAY75, QCR2-GFP::G418 R This study 
PKY17 HAY75, MDH1-GFP::G418 R This study 
PKY133 HAY809, Mdh1-GFP::G418 R This study 
PKY37 HAY75, ptc5D::NATR This study 
PKY38 PKY37, QCR2-GFP::G418 R This study 
PKY39 PKY37, MDH1-GFP::G418 R This study 
PKY51 PKY37, IDP1-GFP::G418 R This study 
PKY61 HAY75, pkp1D::HIS5 S.p. This study 
PKY69 PKY61, MDH1-GFP::G418 R This study 
PKY70 HAY75, pkp2D, HIS5 S.p. This study 
PKY71 PKY37, ACO1-GFP::G418 R This study 
PKY75 PKY61, ACO1-GFP::G418 R This study 
PKY76 PKY61, ACO2-GFP::G418 R This study 
PKY87 PKY61, QCR2-GFP::G418 R This study 
PKY94 PKY37, ACO2-GFP::G418 R This study 
PKY114 PKY70, ACO1-GFP::G418 R This study 
PKY115 PKY70, ACO2-GFP::G418 R This study 
PKY116 PKY70, QCR2-GFP::G418 R This study 
PKY117 PKY70, MDH1-GFP::G418 R This study 
PKY122 PKY61, IDP1-GFP::G418 R This study 
PKY129 PKY70, IDP1-GFP::G418 R This study 
PKY136 HAY809, QCR2-GFP::G418 R This study 
PKY151 HAY809, ACO1-GFP::G418 R This study 
PKY152 HAY809, ACO2-GFP::G418 R This study 
PKY186 HAY809, IDP1-GFP::G418 R This study 
PKY334 HAY1239, MDH1-GFP:: HIS5 S.p This study 
PKY365 HAY75, mdh1D::HIS5 S.p. This study 
PKY392 TVY1, MDH1 GFP::G418 R This study 
PKY395 TVY1, aup1D::HIS5 S.p. This study 
PKY415 PKY395, Mdh1-GFP::G418 R This study 
PKY456 PKY365, aup1D::HIS5 S.p. This study 
PKY488 PKY365, pkp2D (DP) This study 
PKY520 TVY1, arg4D:: G418 R This study 
PKY629 PKY70, pkp1D (DP) This study 
PKY661 PKY395, arg4D:: G418 R This study 
PKY629 PKY70, pkp1D (DP) This study 
PKY670 PKY629, QCR2-GFP::G418 R This study 
PKY672 PKY629, MDH1-GFP::G418 R This study 
PKY673 PKY629, ACO1-GFP::G418 R This study 
PKY681 PKY629, IDP1-GFP::G418 R This study 
PKY682 PKY629, ACO2-GFP::G418 R This study 
PKY734 TVY1, aup1D:: NATR This study 
PKY826 TVY1, Cit1-HA:: HIS5 S.p. This study 
PKY827 TVY1, Mic60-HA:: HIS5 S.p. This study 
PKY824 PKY734, Cit1-HA:: HIS5 S.p. This study 
PKY825 PKY734, Mic60-HA:: HIS5 S.p. This study 
HAY339 atg1D :: LEU2 This study 
PKY915 TVY1, pkp2D::HIS5 S.p. This study 
PKY535 PKY365, QCR2-RFP::G418 R This study 
PKY1025 HAY75, Mdh1-RFP:: G418 R, Qcr2-
GFP:: HIS5 S.p. 
This study 
PKY1054 HAY75, aup1D:: NATR , Mdh1-RFP:: 
G418 R, Qcr2-GFP:: HIS5 S.p. 
This study 
PKY1032 TVY1, Idh1-HA:: HIS5 S.p. This study 
PKY1040 PKY734, Idh1-HA:: HIS5 S.p. This study 
 
 
 
 
Supplementary Table III.  Plasmids used in this study 
 
 
Plasmid Description Backbone 
vector 
RE sites in 
backbone 
vector/insert 
Yeast 
Markers 
Insert Cloning 
Primers 
Reference/ 
source 
pCU416 - - URA3 - - - (Labbe S et al.., 
1999) 
pRS415 - - LEU2 - - - (Sikorsky R et 
al., 1989) 
pDJB11 pCU416-
mtRFP 
pCU416 HindIII, XhoI URA3 mtRFP - (Journo et al., 
2009) 
pDJB12 pCU414-
mtRFP 
pCU414 HindIII, XhoI TRP1 mtRFP - This study 
pPKB1 pCU416-
AUP1 
pCU416 ClaI, SpeI URA3 AUP1 P1,P2 This study 
pPKB2 pCU416-
34DAUP1 
pCU416 ClaI, SpeI URA3 34DAUP1 P3,P4 This study 
pPKB24 pRS415- 
MDH1T199A-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199A-GFP 
P5,P6 This study 
pPKB25 pRS415- 
MDH1S177A-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S177A-GFP 
P5,P6 This study 
pPKB26 pRS415- 
MDH1S196A-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S196A-GFP 
P5,P6 This study 
pPKB27 pRS415- 
MDH1S240A-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S240A-GFP 
P5,P6 This study 
pPKB28 pRS415- 
MDH1T59A-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T59A-GFP 
P5,P6 This study 
pPKB37 pRS415- 
MDH1S196D-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S196D-GFP 
P5,P6 This study 
pPKB40 pRS415- 
MDH1T199D-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199D-GFP 
P5,P6 This study 
pPKB45 pRS415- 
MDH1T199A-
s240A-S196A-
pRS415 BamHI, SacI LEU2 [MDH1p]- P5,P6 This study 
S177A-T59A-
GFP 
MDH1T199A-s240A-
S196A-S177A-T59A-
GFP 
pDJB11 pCU416-
IDP1-GFP 
pCU416 - URA3 IDP1-GFP - (Journo et al, 
2009) 
pPKB65 pRS415-
MDH1-GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1-GFP 
P5,P6 This study 
pPKB73 pRS415- 
MDH1T59D-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T59D-GFP 
P5,P6 This study 
pPKB74 pRS415- 
MDH1S240D-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S240D-GFP 
P5,P6 This study 
pPKB75 pRS415- 
MDH1S177D-
GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1S177D-GFP 
P5,P6 This study 
pPKB76 pRS415- 
MDH1T199D-
s240D-GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199D-s240D-
GFP 
P5,P6 This study 
pPKB77 pRS415- 
MDH1T199D-
s240A-GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199D-s240A-
GFP 
P5,P6 This study 
pPKB78 pRS415- 
MDH1T199A-
s240D-GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199A-s240D-
GFP 
P5,P6 This study 
pPKB79 pRS415- 
MDH1T199A-
s240A-GFP 
pRS415 BamHI, SacI LEU2 [MDH1p]- 
MDH1T199A-s240A-
GFP 
P5,P6 This study 
pPKB82 pCU416-
MDH1-GFP 
pCU416 ClaI, SpeI URA3 [MDH1p]-
MDH1-GFP 
P7,P8 This study 
pPKB83 pCU416-
17DMDH1-
GFP 
pCU416 ClaI, SpeI URA3 17DMDH1-GFP P9,P10 This study 
pPKB84 pCU416-
17DMDH1 
T199A -GFP 
pCU416 ClaI, SpeI URA3 17DMDH1 T199A 
-GFP 
P9,P10 This study 
pPKB88 pRS414-
MDH1-GFP 
pRS414 BamHI, SacI TRP1 [MDH1p]- 
MDH1-GFP 
P5,P6 This study 
pPKB89 pCU416-
PKP1 
pCU416 ClaI, SpeI URA3 PKP1 P11,P12 This study 
pPKB90 pCU416-
PKP2 
pCU416 ClaI, SpeI URA3 PKP2 P13,P14 This study 
pKB33 pYX142 
mt-GFP 
pYX142 
 
 LEU2 mtGFP - Westermann B., 
et al., 2000 
pKB115 pYX142 
mt-DHFR-
GFP 
pYX142 
 
BamHI, BglII LEU2 Mt-DHFR-GFP P15, P16 This study 
 
 
 
 
Supplementary Table IV.  Oligonucleotides used in this study 
Primers Purpose Primers  
P1 Amplification of AUP1 
for the construction of 
pKPB1 
Forwrard:5' ATACTAACTAGTTACAACATGCGGCTGGGGAATCTATG 3' 
P2 Reverse:  5 'ATACTAATCGATTTAGTTTAATTTTGTTTCGTTAGATTG3' 
P3 Amplification of  
aup1D34 for the 
construction of 
pKPB2 
Forward:5'ATACTAACTAGTTACAACATGAGTAGGATCAACCGGTTAG3' 
P4 Reverse:  5 'ATACTAATCGATTTAGTTTAATTTTGTTTCGTTAGATTG3' 
P5 Amplification of  MDH1-
GFP for  the construction 
of pPKB65 ,  under native 
promoter of MDH1.  
Forward:  5 'ATACTAGGATCCCAAAAGATCGACGCAATG3' 
P6 Reverse: 5'ATACTAGAGCTCGACCTCATACTATACCTG3' 
P7 Amplification of  MDH1-
GFP for  the construction 
of  pKPB82 
Forward: 5'ATACTAACTAGTTACAACATGTTGTCAAGAGTAGCTAAAC3' 
P8 Reverse: 5'ATACTAATCGATGACCTCATACTATACCTG3' 
P9 Amplification of  
MDH1D17 for the 
construction of 
pPKB83&pPKB84 
Forward: 5'ATACTAACTAGTTACAACATGTATAAAGTGACTGTTTTG 
P10 Reverse: 5' ATACTAATCGATGACCTCATACTATACCTG   
P11 Amplification of  PKP1 
for  the construction of  
pKPB89 
Forward: 5' ATACTAACTAGTTACAACATGTGGAAGATTATGCGTTC 
P12 Reverse: 5'  ATACTAATCGATTTACTTTTTGGAGAGTAGTG 
P13 Amplification of  PKP2 
for  the construction of  
pPKB90 
Forward: 5'  ATACTAGGATCCTACAACATGTCTAAGTATCAAATTAA 
P14 Reverse: 5'  ATACTAATCGATTCACACTTTATCTAATTGTAG 
P15 Amplification of  DHFR 
for  the construction of  
pKB115 
Forward: 5'   ATACTAGGATCCTACAACATGATCAGTCTGATTGCGG 
P16 Reverse: 5'   ATACTAAGATCTCCGCCGCTCCAGAATCTC 
D1 Amplification of natMX4 
cassette for the deletion of   
ptc5D 
Forward: 5' TTTCAACAGAAGAAGTGCTTTTACTTCTCT CAATCTCTCC3' 
D2 Reverse: 5'ATCCTCTGGTATATACCTACCTCAGCATAAGTTTATATC 
D3 Amplification of   His5 
S.p.  cassette for the 
deletion of pkp1D 
Forward:5'ACCAACTCTTTGTATTTGAAAAGCTTGCAAACGTTGCTATCCCG
GGCTGCAGGAATTC3' 
D4 Reverse:5'TAAGTACAGCTCGTCATCGTCTGGCTTTAAAAGATTGATCTCGA
CGGTATCGATAAGC3' 
D5 Forward:5'ATCGTGAGAGATTGGTCAATGGATAAATAGTTCTGTAATT 
CCCGGGCTGCAGGAATTC 3' 
D6 Amplification of   His5 
S.p.  cassette for the 
deletion of 
pkp2D 
Reverse: 5'GGATAACTCATTGGTTCTAGCGACGTGTGCATGTACGGTT  
TCGACGGTATCGATAAGC 3' 
D7 Amplification of   His5 
S.p.  cassette for the 
deletion of mdh1D 
Forward:5'AAGAAAAAAAACAAAAGGAAAAGGAAGGATACCATATACACC
CGGGCTGCAGGAATTC3' 
D8 Reverse:5'TTCGGATTTGAACAAGGGAGAGTCCACGAAGGAAGGCTCGTCG
ACGGTATCGATAAGC3' 
D9 Amplification of   G418R  
cassette for the deletion of 
arg4D 
Forward:5'GCTCAAAAGCAGGTAACTATATATAACAAGACTAAGGCGGTG
GTCTTGCGCAACACG 
D10 Reverse:5'CTAATTTAATTGGGATTTCAAATTATCCAATTGCTTCAATGAAT
TCGAGCTCGTTTAAAC 
T1 Amplification of   His5 
S.p.  cassette for the 
tagging of Mic60-HA 
Forward:5'GCGCCTGGTAGAGATTCTTGACTGTGAAATAAGGACGTTGTAC
CCATACGATGTTCCTG 
T2 Reverse:5'ATCGGAAATGACGAGTAACAGCTAACTTACATTTTAGGTTCGA
CGGTATCGATAAGC 
T3 Amplification of   His5 
S.p.  cassette for the 
tagging of Cit1-HA 
Forward:5'AAAATACAAGGAGTTGGTAAAGAAAATCGAAAGTAAGAACTA
CCCATACGATGTTCCTG 
T4 Reverse:5'GTAGGCATAGGGGACTCAAAGCGTAAAAATCATGAAGTCATCG
ACGGTATCGATAAGC 
M19 
Site Directed Mutagenesis 
of S240A on Mdh1-GFP 
Forward:5'GCAAAGAATGGTGCTGGCGCTGCTACGTTGTCAATGGC3' 
M20 Reverse:5' GCCATTGACAACGTAGCAGCGCCAGCACCATTCTTTGC 3' 
M1 Site Directed Mutagenesis 
of T199A on Mdh1-GFP 
Forward: 5'CGGTGGACATTCTGGTATCGCGATCATCCCATTGATTTCG3' 
M2 Reverse:5'CGAAATCAATGGGATGATCGCGATACCAGAATGTCCACCG3' 
M3 Site Directed Mutagenesis 
of S196A on Mdh1-GFP 
Forward: 5'CGGTGGACATGCTGGTATTGCCATCATCCCATTGATTTCG3' 
M4 Reverse: 5'CGAAATCAATGGGATGATGGCAATACCAGCATGTCCACCG3' 
M5   Site Directed 
Mutagenesis of S177A on 
Mdh1-GFP 
Forward: 5'GAGCCGCCAGATTCATCGCAGAAGTCGAGAACAC3' 
M6 Reverse: 5'GTGTTCTCGACTTCTGCGATGAATCTGGCGGCTC3' 
M7   Site Directed 
Mutagenesis of T59A on 
Mdh1-GFP 
Forward: 5'GGGCGCAAAAGGTGTTGCCGCCGATTTGTCTCATATTC3' 
M8 Reverse: 5'GAATATGAGACAAATCGGCGGCAACACCTTTTGCGCCC3' 
M9 
Site Directed Mutagenesis 
of S240D on Mdh1-GFP 
Forward: 5'CAAAGAATGGTGCTGGCGATGCTACGTTGTCAATGGC3' 
M10 Reverse: 5'GCCATTGACAACGTAGCATCGCCAGCACCATTCTTTG3' 
M11 
Site Directed Mutagenesis 
of T199D on Mdh1-GFP 
Forward: 5'GGTGGACATTCTGGTATTGATATCATCCCATTGATTTCGC3' 
M12 Reverse: 5'GCGAAATCAATGGGATGATATCAATACCAGAATGTCCACC3' 
M13 Forward: 5'CGTCATCGGTGGACATGATGGTATTACCATCATC3' 
 M14 Site Directed Mutagenesis 
of S196D on Mdh1-GFP 
Reverse: 5'GATGATGGTAATACCATCATGTCCACCGATGACG3' 
M15 
Site Directed Mutagenesis 
of S177D on Mdh1-GFP 
Forward: 5'GAGCCGCCAGATTCATCGATGAAGTCGAGAACACCG3' 
M16 Reverse: 5'CGGTGTTCTCGACTTCATCGATGAATCTGGCGGCTC3' 
M17 
Site Directed Mutagenesis 
of T59D on Mdh1-GFP 
Forward: 5'GCGCAAAAGGTGTTGCCGATGATTTGTCTCATATTCCAAC3' 
M18 Reverse: 5'GTTGGAATATGAGACAAATCATCGGCAACACCTTTTGCGC3' 
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